Allworth Financial’s Vanda Pharmaceuticals VNDA Stock Holding History

Allworth Financial’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$42.9K	Sell	7,009 -5,292	-43%	-$34.6K	﹤0.01%	2616
2026 Q1	$85K	Buy	12,301 +11,756	+2,157%	+$90.7K	﹤0.01%	1940
2025 Q4	$4.81K	Sell	545 -287	-34%	-$1.58K	﹤0.01%	3734
2025 Q3	$4.15K	Buy	+832	New	+$3.85K	﹤0.01%	3656
2023 Q4	–	Sell	-98	Closed	-$424	–	3630
2023 Q3	$424	Buy	98 +61	+165%	+$339	﹤0.01%	3082
2023 Q2	$244	Buy	+37	New	+$237	﹤0.01%	3058
2022 Q4	–	Sell	-1,234	Closed	-$12K	–	3214
2022 Q3	$12K	Buy	+1,234	New	+$13K	﹤0.01%	1581

Other funds holding VNDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allworth Financial's VNDA Position: Q2 2026 in Review

Allworth Financial reduced its Vanda Pharmaceuticals (VNDA) stake by 43% in Q2 2026, selling an estimated $34.6K and leaving 7,009 shares worth $42.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2616.

Allworth Financial first reported a position in VNDA in Q3 2022 and has held it in 7 quarters since. The position peaked at $85K in Q1 2026. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

Allworth Financial held 7,009 shares of Vanda Pharmaceuticals worth $42.9K as of Q2 2026.
Allworth Financial sold 5,292 Vanda Pharmaceuticals shares in Q2 2026, an estimated $34.6K.
Vanda Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2616 holding.
Allworth Financial first reported a position in Vanda Pharmaceuticals in Q3 2022 and has held it in 7 quarters since.
Allworth Financial's Vanda Pharmaceuticals position peaked at $85K in Q1 2026.
172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.